Brian R. Skene

ACD/CD/Senior Copy Creative

"The universe is made of stories, not atoms."

—Muriel Rukeyser

brianskene@yahoo.com

(m) 908.432.8081

Basking Ridge, NJ

portfolio website: brianrskene.com

(password available upon request)

Therapeutic Expertise

Oncology, gene therapy, rare disease, respiratory, CNS (MS, MDD, schizophrenia, pseudobulbar affect), cardiology, dermatology, diabetes, hematology, HIV, stroke, hemophilia, surgical devices, acid reflux disease, infertility

Pitchwork

Led copy development for 2 successful new business pitches:

• VYJUVEK / Krystal Biotech (dystrophic epidermolysis bullosa)

• ARCUS BioSciences (cancer immunotherapy)

Selected Work

VYJUVEK / Krystal Biotech
Gene therapy, dystrophic epidermolysis bullosa
Led prelaunch creative for the first FDA-approved redosable topical gene therapy

XARELTO / Janssen Pharmaceuticals
Anticoagulation, multiple indications
Oversaw strategic copy for 7th and 8th indications; institutional, LTC, and HCP rollouts

AMONDYS45 / Sarepta Therapeutics
RNA-based therapy for Duchenne muscular dystrophy
Built launch platform; managed relaunch of Duchenne.com (HCP + patient)

UTIBRON / SEEBRI / ARCAPTA / Sunovion
Respiratory triple launch
Drove creative across brands and markets; supported post-launch growth into consumer and LTC

BREO + ARNUITY / GlaxoSmithKline
Asthma + COPD
Breo launch called "most flawless in GSK history"

OCREVUS / Genentech
Multiple sclerosis
Created unbranded platform + global messaging in anticipation of launch

Experience

ACD (Freelance)

Eversana Intouch, Avalere Health, Broth Agency

2023—Present

• Created pre-launch tactics for CASGEVY, first FDA-approved CRISPR/Cas9 therapy for sickle-cell disease and β-thalassemia

• Supported launches for LYMPHIR (r/r CTCL), NEMLUVIO (atopic dermatitis/prurigo nodularis), EPKINLY (diffuse large B-cell lymphoma), and LIVDELZI (primary biliary cholangitis)

• Help created HCP and patient tactics for TYVASO (interstitial lung disease) and RADICAVA (amyotrophic lateral sclerosis)

ACD (Fulltime)

McCann Health New York/IPG

2021—2023

• Pitch wins: ARCUS BIOSCIENCES (cancer immunotherapy); KRYSTAL BIOTECH (dystrophic epidermolysis bullosa)

• Copy Lead on SAREPTA THERAPEUTICS' RNA-based Duchenne Muscular Dystrophy franchise

• Relauched LEVULAN KERASTICK + BLU-U & ODOMZO for SUN PHARMA

• Mentored junior writers, co-taught agency workshop on creative briefs

ACD (Freelance)

RealityRx/Various

2018—2020

• Led copy development for 7 INTEGRA LIFESCIENCES relaunches (surgical devices)

VP ACD

Concentric Health Experience

2017—2018

• Directed creative across 4 workstreams; managed 8 writers for launch of SUNOVION respiratory franchise

• Messaging lead on REXULTI (MDD and Schizophrenia) for OTSUKA/LUNDBECK

GROUP COPY SUPERVISOR

Ogilvy CommonHealth

2015—2016

• Developed global and US tactics for OCREVUS (multiple sclerosis) and BYDUREON (type II diabetes)

ALSO

• Wrote/directed/produced 50+ nationally distributed health and culture programs for PBS and LifeTime Medical Television

• Nominated for 4 Emmy nominations, including Best Health Program and Best Research

EDUCATION

Colby College— BA Biology

University of Exeter (UK)— Biology/Psychology